glp-1 degradation profiles of (A and B) GLP-1, (C) N-acetyl-GLP-1 and (D) Frontiers | Mechanisms of action

Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4

Diabetes Care (2015) 38(2):26470

Subsequent cohorts were dosed after the dosing regimen in the preceding cohort was recommended to be safe and well tolerated based on the safety and laboratory data through at least day 15

A recent publication has detailed the user profile of semaglutide 2.4-mg in real-world settings during this timeframe, which helps identify if this group is at risk for osteoporosis [21]

doi: 10.1016/j.cmet.2016.06.009 124 VermaSMcGuireDKBainSCBhattDLLeiterLAMazerCDet al

The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (grant number NNF14CC0001)